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Thallium-201 imaging has been utilized to estimate myo-
cardial salvage after thrombolytic therapy for acute
myocardial infarction. However, results from recent an-
imal studies have suggested that as a result of reactive
hyperemia and delayed necrosis, thallium-2ot imaging
may overestimate myocardial salvage. To determine
whether early overestimation of salvage occurs in hu-
mans, intracoronary thallium-201 scans 1 hour after
thrombolytic therapy were compared with intravenous
thallium-201 scans obtained approximately 10 and 100
days after myocardial infarction in 29 patients.
In 10 patients with angiographic evidenceof coronary
reperfusion, immediate improvement in thallium defects
and no interim clinical events, there was no change in
imaging in the follow-up studies. Of nine patients with
coronary reperfusion but no initial improvement of per-
Intracoronary thallium-20 I scintigraphy has been used be-
fore and after thrombolytic therapy to demonstrate that re-
perfusion of occluded coronary arteries results in improved
myocardial perfusion. which is a necessary precondition for
myocardial salvage (1-4). This technique can be applied
conveniently at the time of intracoronary administration of
a thrombolytic agent. However. recent reports have sug-
gested that the acute pattern of thallium-20 I scintigraphy
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fusion defects, none showed worsening of defects in the
follow-up images. Six of these patients demonstrated
subsequent improvement at either 10 or 100 days after
infarction. Seven of 10 patients with neither early evi-
dence of reperfusion nor improvement in perfusion de-
fects had improvement of infarct-related perfusion de-
fects, and none showed worsening.
Inconclusion, serial scanning at 10and 100days after
infarction in patients with no subsequent clinical events
showed no worsening of the perfusion image compared
with images obtained in acute studies. Therefore, there
is no evidencethat thallium-2ot imaging performed early
in patients with acute myocardial infarction overesti-
mates improvement.
(J Am Coil CardiolI987;9:300-7)
may not accurately predict the amount of long-term salvage.
For example, Okada and Pohost (5) showed in a dog coro-
nary occlusion/reflow model that. because of reactive hy-
peremia. the image seen during acute reperfusion overes-
timates that seen at 24 hours. Forman and Kirk (6) showed
in a similar dog model that early thallium-20l uptake and
myocardial blood flow demonstrated by a radioactive mi-
crosphere technique provided higher blood flow values than
those observed 24 hours after occlusion. The reduction in
blood flow between the early reperfusion study and the study
carried out 24 hours later may have been due to delayed
necrosis after reflow. Both of these effects would result in
an early thallium image that would show more activity in
the area of infarction than would a subsequent thallium
Image.
To determine if these two mechanisms are clinically im-
portant, we studied 29 patients who received intracoronary
thrombolytic therapy. Thallium-20l scans obtained by intra-
coronary injection of the isotope immediately after throm-
bolytic therapy were compared with intravenous scans
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obtained after intravenous injection of the isotope at ap-
proximately 10 and 100 days after myocardial infarction,
Our purpose was to determine whether a reduction in thal-
lium-20I uptake occurred in the scintigrams obtained late
(10 and 100 days after treatment) compared with those ob-
tained immediately after thrombolysis,
Methods
Patient selection. Forty patients who presented within
3 hours after the onset of symptoms of acute Q wave myo-
cardial infarction and whose electrocardiogram showed acute
ST segment elevations not altered by sublingual nitroglyc-
erin gave written informed consent for the intracoronary
administration of streptokinase or urokinase, The protocol
was approved by the Human Studies Committee of the Beth
Israel Hospital. Boston. Massachusetts. The time from onset
of symptoms to thrombolysis was 4 to 6 hours, Five patients
(three of whom died early) were excluded because they did
not have follow-up studies; five patients were excluded be-
cause only one coronary artery was injected. and one patient
was excluded because suboptimal catheter position resulted
in thallium-20I streaming that produced a defect in an un-
involved artery.
Protocol. In the cardiac catheterization laboratory, the
noninfarct-related coronary artery was first visualized by
coronary cineangiography. Thallium-20I was injected di-
rectly into this vessel. The infarct-related coronary artery
was then evaluated by cineangiography. and thallium-20I
was injected, To minimize the effects of the postcontrast
hyperemia. the time betweencontrast injectionand thallium-
201 injection was at least 3 minutes, After thrombolytic
therapy, a second set of injections of thallium-20I was ad-
ministereddirectly into both the involvedand the uninvolved
arteries and a second set of images was obtained.
The second set ofimages (postthrombolytic therapy) was
obtained with a dose of thallium-20I that was 10 times that
used for the first (prethrombolytic) images, For each dose
of thallium-20I. three-eighths of the activity was injected
into the right coronary artery and five-eighths into the left
coronary artery (7). Because the thallium was injected di-
rectly into the coronary circulation, there was a high per-
centage of myocardial uptake of thallium with little back-
ground activity. Therefore, a very small radioactive dose
could be used for the initial images, and the whole procedure
could be performed with the usual dose (80 MBq [2.2 mCij).
Imaging after the first intracoronary injection of thal-
lium-20I was performed in the cardiac catheterization lab-
oratory during the infusion of thrombolytic agent. This did
not require an alteration in the procedure or treatment pro-
tocol. Scanning of postthrombolytic therapy imaging was
also performed in the cardiac catheterization laboratory. A
camera (Technicare410 Mobile) with a slant hole collimator
was used, Views obtained were anterior, modified left an-
terior oblique and 70° left anterior oblique projections,
At approximately 10 and 100 days after the acute myo-
cardial infarction and initial study, the patients returned to
the Nuclear Medicine Division for evaluation, Most patients
performed exercise testing with intravenous injection of
thallium-20I at peak exercise (submaximal exercise at 10
days, symptom-limitedexercise at 100days), Redistribution
images were obtained 3 to 4 hours after the initial views.
Because of contraindications to exercise. only rest thallium-
20I scans were obtained at the 10 day study in seven pa-
tients, Imagesobtained in the acute study (postthrornbolysis)
were compared with either the redistribution images (in the
22 patients who exercised) or to rest images in the other 7
patients.
Interpretation of thallium-2Ot images. Thallium-20l
scans were interpreted simultaneously by three observers
who did not know the angiographic results of thrombolytic
therapy. Each image was divided into five segments and
each segment was scored (0 = normal; I = slightly but
definitely abnormal: 2 = moderately abnormal; and 3 =
absent activity) (8). An image score for each segment was
obtained by consensus, with the total score being the sum
of all segment scores. We have previously shown (3) that
this scoring method is reproducible and unbiased, By this
method, any change of three scoring units or more was
considered to represent a real change, In addition to the
global scores, the thallium scans were analyzed for regional
changes to maximize sensitivity to changes in the infarcted
area. The regions with the highest score (least thallium-20I
uptake) on the prethrombolytic therapy images were iden-
tified. The same scoring system was used for this analysis
except that any change in score was noted. These segments
were compared in the postthrombolysis 10day and 100day
scans,
Determination of successful thrombolytic therapy.
Success of thrombolytic therapy was based on improvement
demonstratedon coronary angiogramsas well as on thallium
scans, The area of myocardium supplied by the infarct-
related artery was correlated with the initial perfusion defect
obtained by thallium-20I imaging. Successful reperfusion
was defined as flow equal to that seen in uninvolved vessels
with normal washout of contrast medium, This had to be
confirmed on the last films taken before removal of cathe-
ters. In two patients (Cases 21 and 22), coronary patency
was initially established, but subsequent films revealed oc-
clusion. These two patients were classified as having un-
successful reperfusion and. in both cases, thallium-201 im-
aging did not change.
Results
The patients were classified into three groups. depending
on the results of the coronary cineangiogram and thallium-
20I perfusion scans,
Group L Ten of the 29 patients exhibited successful
reperfusion by angiography as well as improved thallium
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Table 1. Comparison of Intracoronary and Intravenous Thallium-20l Scores in 29 Patients
After Lysis
Patient No. Before Lysis Immediate 10Days 100 Days
Group [ Scores. Improved Angiographically/lmproved Thallium
I 17 8 6 7
2 16 8 8
3 10 4 4 5
4 5 2 4 4
5 14 10 II 12
6 5 I 0 0
7 18 14 14 12
8 14 5 6
9 12 2 4
10 9 6 5
Group II Scores. Improved Angiographically/No Improvement in Thallium
II 5 5 3
12 2 I I 0
13 7 8 5 4
14 6 6 7 2
15 15 14 5 2
16 4 4 0 0
17 14 13 7 7
18 21 19 14
19 15 15 14
Group III Scores. No Improvement Angiographically/No Improvement in Thallium
20 22 22 15 16
21 15 16 13
22 12 12 8 8
23 6 6 5 6
24 15 13 17 13
25 9 9 4
26 7 9 3
27 12 13 10 12
28 16 13 II 6
29 15 12 5 4
imaging after thrombolytic therapy (Table I. Fig. l ). In
eight of these patients, minimal changes occurred between
the immediate postthrombolysis images and the 10 and lOO
day images. In two patients (Cases 5 and 9) there was
worsening by two score units; however, these changes were
within the variability of the scoring method (3). An example
of the thalllum-201 images from a patient (Case 3) in this
group is shown in Figure 2. There was no change in the
infarcted area seen in this patient in the 10 and 100 day
scans compared with the postthrombolytic scan.
The regional scores in the patients who showed improve-
ment by thallium scanning and by angiography showed no
tendency toward worsening of thallium defects at 10 or 100
days (Table 2, Fig. 3). One patient exhibited deterioration
in regional score by a single score unit, whereas improve-
ment in the thallium scores (by one unit or greater) was
observed in five patients.
Group II. Nine patients had angiographic evidence of
successful reperfusion but no improvement by thallium scin-
tigraphy. None of these patients showed worsening of their
thallium-20l defect scores in the follow-up images by more
than one unit. In c0'1trast with Group I, six of these nine
patients showed improvement by three or more units in
either the 10 or the 100 day scans compared with their
immediate postthrombolytic scan. In these patients there
was successful reperfusion by angiography but no reper-
fusion by thallium imaging, demonstrating the difference
between these two measures of thrombolytic efficacy. Of
the patients classified as having angiographic but no thallium
evidence of improvement, none showed worsening of their
regional thallium scores, and improvement was noted in
seven of these patients.
Group III. These 10 patients had neither angiographic
nor thallium scintigraphic evidence of improvement after
thrombolytic therapy. Only one of these patients (Case 24)
had a worsening image on the 10 day scan compared with
the immediate posttherapy scan. However, in this patient
the 100 day image score was similar to that obtained im-
lACC Vol. Y. No.2
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Figure I. Comparison of global thallium-20 I imaging scores after
thrombolytic therapy (intracoronary) with follow-up studies ap-
proximately 10and \00 days after therapy (post Rx) (intravenous).
III = improved angiographically/improved with thallium-20 I
(n = 10): liN = improved angiographically/not improved with
thallium-2ot (n = 9): NIN = not improved angiographically/not
improved with thallium-201 (n = \0).
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mediately after therapy. Improvement of thallium imaging
score by three or more units between immediate posttreat-
ment and the 10 day and 100 day scans was noted in 7 of
the 10 patients.
Discussion
Because thrombolytic therapy for acute myocardial in-
farction has become increasingly important, there has been
substantial interest in evaluating the efficacy of this treat-
ment. One approach consists of thallium-20l scintigraphy
before and after thrombolytic therapy (1-4). However, re-
cent evidence from animal models (5,6) has suggested that
this technique may overestimate myocardial salvage. To
determine whether this occurred in a clinical setting, we
evaluated thallium images obtained immediately after
thrombolytic therapy with images obtained 10 and 100days
later. If overestimation of perfusion had occurred on the
posttherapy scans, then worsening of the thallium images
should occur at 10and 100days after thrombolytic therapy.
This was not observed in our study.
Figure 2. Case 3. Thallium-2ot scans before therapy (PRE-
Rx) and immediately (POST-Rx) and 10 and 100 days after
therapy. The scan obtained before therapy shows a defect in
the posterior and posterolateral walls. The posttherapy scan
shows improvement in perfusion that does not change in the
10 and 100 day scans. ANT = anterior: MLAO = modified
left anterior oblique: 700 LAO = left anterior oblique.
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Table 2. Comparison of Regional Intracoronary and Intravenous Thallium-20 I Scores
in 29 Patients
After Lysis
Patient No. Before Lysis Immediately 10 Days 100 Days
Group I Scores. Improved Angiographically/Improved Thallium
I 9 5 3 5
2 3 I I
3 6 I I I
4 5 2 3 4
5 6 4 4 4
6 4 I 0 0
7 12 8 6 6
8 6 I 0
9 8 2 I
10 4 2 2
Group II Scores. Improved Angiographically/No Improvement in Thallium
II 3 3 2
12 2 0 0 ()
13 4 4 2 0
14 2 2 1 0
15 9 9 3 I
16 4 I 0 0
17 3 3 2 2
18 6 6 6
19 6 6 3
Group III Scores. No Improvement Angiographically/No Improvement in Thallium
20 18 16 II 13
21 I} I} 8
22 3 3 I
23 2 2 2 2
24 6 6 5 5
25 8 8 4
26 2 2 I
27 6 7 3 6
28 3 3 I 2
29 I} 6 4 3
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Intracoronary Versus Intravenous Administration
of Thallium-201
Major factors affecting proportionality of thallium
uptake to regional blood flow. In this study, images ob-
tained after intracoronary injection of thallium-20l were
compared with those obtained after intravenous injection of
the same radiopharmaceutical. It is therefore important to
consider the mechanisms of uptake of thallium-201 by the
myocardium and the possible effects the two administration
techniques may have had on the results. Intravenous thal-
lium-201 is widely used and accepted as an indicator of
relative regional myocardial blood flow (9,10). The pro-
portionality of thallium-201 to regional blood flow is de-
pendent on three major factors: I) that thallium-20 I is well
mixed in the blood flow; 2) that there is uniform extraction
of thallium-20 I; and 3) that there is no redistribution of the
indicator (II).
Uniform thallium mixing in blood flow. Although thal-
lium-201 is well mixed in the coronary blood flow when
injected intravenously, it may not be when injected directly
into the coronary artery beds. For example, the relative
amount of thallium-20 I injected into the right and left coro-
nary arteries (a ratio of 3:5) is an estimate of the relative
blood flows in these vessels but may not be accurate in
individual patients. Furthermore, within a single artery there
may be either subselective positioning of the catheter or
streaming of the indicator during injection. Intracoronary
injection will also not assess any contribution to myocardial
perfusion through noncoronary collateral vessels (12). When
comparing images obtained by intracoronary or intravenous
injections, the former may therefore show some heteroge-
neity of uptake due to inadequate mixing, or could result
in pseudonormalization. Nonuniform mixing could also
produce regional abnormalities, that is, areas of relatively
high activity on the immediate posttherapy study as com-
JACC Vol. 9. No.2
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Figure 3. Comparison of regional thallium-20 I imaging scores
after thrombolytic therapy (intracoronary) with follow-up studies
approximately 10 and 100 days after therapy (intravenous) in the
three patient groups. Abbreviations as in Figure I.
pared with the follow-up studies. However, the infrequency
of such regional abnormalities in our study suggests that
nonuniform mixing was not a major problem with intra-
coronary injections.
Uniform extraction of thallium. The second requirement
for accurate blood flow measurement is uniform fractional
extraction of thallium-20I. Fractional extraction is reduced
by acidosis and hypoxia and by nonnutrient increases in
coronary blood flow that may be secondary to the actions
of adenosine, minoxidil, dipyridamole and reactive hyper-
emia (13,14). (However, increased blood flow due to tread-
mill exercise in the dog showed a linear relation to micro-
sphereblood flow [151.) At very low flow rates, the fractional
extraction increases, resulting in a slightly greater thallium-
201 uptake relative to blood flow. Uptake of thallium, like
uptake of potassium, is mediated by a sarcolemmalouabain-
inhibited sodium/potassium adenosine triphosphatase (16,17).
Furthermore, uptake of thallium by myocytes studied in
tissue culture correlates well with cell viability (18). Thus,
myocardial uptake of thallium appears to require viable cells
with an active sodium/potassium pump. If areas of nonvi-
able myocardium were perfused, then thallium-201 uptake
in these areas would underestimate blood flow. Because
thallium-20I uptake correlates with blood flow in reperfused
and nonreperfused models of myocardial infarction in the
dog (19) and in patients with infarction (20), it appears that
nonviable myocardium does not receive appreciable blood
flow.
Absence of thallium redistribution. The third require-
ment for measurement of relative blood flow is the absence
of redistribution. Thallium-201 activity continually washes
out of the myocardium and thallium-20I from the body pool
continually returns to be taken up by the myocardium. Intra-
coronary administration of thallium-201 minimizes the sec-
ond problem. Becausethe body pool ofthallium-201 is small
relative to the myocardial activity, there is relatively little
activity returning to the myocardium. However, there is still
washout of activity that will affect the distribution of thal-
lium-201.
Difficulties in comparisons of intravenous and intra-
coronary thallium scans. In this study, both rest and re-
distribution scans obtained after intravenous injection of
thallium-201 were used for comparison with the initial intra-
coronary scans. The comparison between intracoronary and
intravenous methods of administration was necessary be-
cause these patients did not receive a second cardiac cath-
eterization and the initial intracoronary scans were utilized
for patient stratification. There are, however, inherent dif-
ficulties in these comparisons.
Reverse redistribution. It has recently been described
(21) in patients after thrombolytic therapy, that scans ob-
tained immediately after intravenous thallium-201 injection
may differ from those obtained 4 hours later, despite the
rest status of both images. These authors (21) described
worsening of thallium-20I imaging in the delayed images,
termed "reverse redistribution." These changes were at-
tributed to a higher than normal washout rate of thallium-
20J in the area of the infarction. Although this pattern was
not seen in our patients, it points out the complex mecha-
nisms of thallium-20I uptake that may occur in the post-
myocardial infarction patient.
Exercised versus nonexercised patients at follow-up. A
second area of difficulty is the combination of thallium-20 I
images obtained from exercised and nonexercised patients
in the follow-up studies. Bias may have been introduced
based on the patient's ability to exercise after myocardial
infarction. Although no clear differences were seen in the
results from these two groups of patients. this division may
have obscured results.
Intracoronary versus intravenous thallium uptake. The
comparison between intracoronary injections and later in-
travenous injections may also introduce error in the results.
The differences between these two delivery techniques are
potentially enormous, as we have discussed earlier. The
assumption we have made by performing this comparison
is that each of these techniques will result in a similar dis-
tribution of thallium-20I that approximates the rest distri-
butionof myocardialblood flow. The similarityof the results
immediately after therapy and at 10 and 100 days in the
patients in Group I is consistent with this assumption. How-
ever, it is important to interpret the results of this study in
light of the considerable differences between these tech-
niques, and our results may be fortuitous.
Comparison With Animal Studies
Role of reactive hyperemia. Okada and Pohost (5) ex-
amined a canine occlusion/reflow model using thallium-20t
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and microspheres. Thallium-201 injected minutes after re-
flow showed increased uptake in the areas of reflow when
compared with 24 hour blood flow. This acute increase in
thallium-20l activity was due to reactive hyperemia as shown
by radioactive microspheres. However, because of de-
creased fractional extraction, the relative increase in thal-
lium-20 I was less than the increase in blood flow.
If reactive hyperemia were important in the present study,
then improvement present in the acute postthrombolytic im-
ages should not persist in the later images (at 10 and 100
days). We did not find any patients in whom the thallium-
20 I scans at 10 and 100 days were appreciably worse than
the scans immediately after therapy (Fig. I). In an attempt
to increase our sensitivity to this condition in the follow-up
scans, we selected the most abnormal segments on the pre-
therapy scan and then compared the posttherapy scan with
the 10 and 100 day scans in those segments. Again, we
were unable to find any patients with worsening of their
scans in the follow-up studies (Fig. 3).
These results, contrary to those in the animal experi-
ments, indicate that reactive hyperemia does not appear to
play an important role in humans. There may be several
reasons for these differences. First, the posttherapy injec-
tions of thallium-20 I were usually made I hour after throm-
bolysis, at a time when the reactive hyperemia may be
reduced. Another important factor may be the duration of
the occlusion. The occlusions in the animal studies were of
relatively short duration (30 minutes to I hour) compared
with those in our studies (4 to 6 hours). Reactive hyperemia
may be less of a factor in occlusions of longer duration.
Furthermore, a residual critical stenosis after thrombolysis
may paradoxically prevent reactive hyperemia.
Demonstration of acute improvement in blood flow with
thrombolysis is a necessary but not a sufficient condition to
demonstrate salvage of myocardium (1,3). The natural his-
tory of thallium-20 I scans after uncomplicated myocardial
infarction includes a reduction in the size of the defect over
time (22,23). Thus, improvement in perfusion after suc-
cessful thrombolysis may represent an acceleration of the
natural time course of later thallium-20 I improvement, as
seen in Group I. Conversely, the later improvement in myo-
cardial imaging in Group III (which neither showed angio-
graphic nor thallium evidence of reperfusions) fits the time
course seen in myocardial infarction with no intervention.
Of equal interest was the improvement from the posttherapy
study to the later studies in patients who showed initial
angiographic improvement but no change in initial thallium-
20 I images. These data suggest that anatomic reperfusion
may have been accomplished, but the myocardial cells could
not immediately respond physiologically, perhaps because
of a "stunned" condition. The fact that the thallium-201
images in the infarcted region should later improve suggests
a transient functional disturbance.
Initial reflow with subsequent myocardial necrosis.
Forman and Kirk (6) investigated a coronary artery occlu-
sion/reflow model in the dog showing regions with initial
reflow that went on to subsequent necrosis; they excluded
animals that showed reactive hyperemia. In areas of the
myocardium that ultimately became necrotic, there was ini-
tial uptake of thallium-20 I, although there was less thallium-
20 I uptake than there was blood flow. Areas with initial
reflow and subsequent necrosis would be expected to show
more thallium-20 I uptake immediately after therapy than at
10 or 100 days (that is, the same pattern as with reactive
hyperemia). Because we did not see any such areas in our
study, this mechanism does not appear to be important in
the clinical situation.
Conclusion. Although experiments in animal models are
necessary to provide information on the behavior of radio-
pharmaceuticals in well-controlled conditions, it is ex-
tremely difficult to design a model that accurately reflects
clinical conditions. Thus, the two mechanisms (reactive hy-
peremia and late necrosis) recently proposed by animal stud-
ies did not play a major role in the use of thallium-20l
imaging in assessing the potential for myocardial salvage
in our patients, because we found no substantial worsening
of the thallium images in follow-up studies. Thus, the use
of intracoronary thallium-20 I injections during intracoro-
nary thrombolytic therapy for acute myocardial infarction
appears to be a useful technique for assessing acute changes
in perfusion that may lead to myocardial salvage.
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